Skip to main content

Rhenman & Partners Asset Management AB

Position in NKTR — Nektar Therapeutics

CIK 1599882 Stockholm, V7

Position in NKTR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,860,662
+$5,615,612 QoQ
Shares Held
141,250
+139.4% QoQ
Ownership
0.414%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#45
of 240 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NKTR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. NKTR ranks #16 (2.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NKTR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,860,662 141,250
2026-03-31 $4,245,050 59,000
2022-12-31 $1,243,000 550,000
2022-09-30 $1,760,000 550,000
2022-06-30 $2,090,000 550,000
2022-03-31 $3,308,834 613,884
2021-12-31 $12,834,500 950,000
2021-09-30 $17,062,000 950,000
2021-06-30 $16,302,000 950,000
2021-03-31 $26,143,920 1,307,196
2020-12-31 $22,950,000 1,350,000
2020-09-30 $16,590,000 1,000,000
2020-06-30 $18,296,400 790,000
2020-03-31 $19,188,750 1,075,000